Ductal carcinomain situ with microinvasion. A curable entity using surgery alone without need for adjuvant therapy
- 15 March 1991
- Vol. 67 (6) , 1498-1503
- https://doi.org/10.1002/1097-0142(19910315)67:6<1498::aid-cncr2820670606>3.0.co;2-i
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Node-negative minimal invasive breast cancer patients are not candidates for routine systemic adjuvant therapyCancer, 1990
- Adjuvant therapy in node-negative breast cancerBreast Cancer Research and Treatment, 1989
- Prolonged Disease-Free Survival after One Course of Perioperative Adjuvant Chemotherapy for Node-Negative Breast CancerNew England Journal of Medicine, 1989
- Efficacy of Adjuvant Chemotherapy in High-Risk Node-Negative Breast CancerNew England Journal of Medicine, 1989
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- A Randomized Clinical Trial Evaluating Sequential Methotrexate and Fluorouracil in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor-Negative TumorsNew England Journal of Medicine, 1989
- Meeting Highlights: Adjuvant Therapy for Breast CancerJNCI Journal of the National Cancer Institute, 1988
- Ductal Carcinoma in Situ (Intraductal Carcinoma) of the BreastNew England Journal of Medicine, 1988
- Noninvasive Breast CarcinomaAnnals of Surgery, 1980
- An Improved Technique for the Study of Lymph Nodes in Surgical SpecimensAnnals of Surgery, 1980